Triamcinolone acetonide - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for triamcinolone acetonide and what is the scope of patent protection?
Triamcinolone acetonide
is the generic ingredient in twenty-seven branded drugs marketed by Abbvie, Chattem Sanofi, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Taro Pharm Inds Ltd, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Cintex Svcs, Glenmark Pharms, Novel Labs Inc, Padagis Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Sanofi Aventis Us, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, and Bausch And Lomb Inc, and is included in one hundred and thirty-five NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Triamcinolone acetonide has one hundred and fifty-two patent family members in twenty-nine countries.
There are twenty-six drug master file entries for triamcinolone acetonide. Sixty-five suppliers are listed for this compound.
Summary for triamcinolone acetonide
International Patents: | 152 |
US Patents: | 7 |
Tradenames: | 27 |
Applicants: | 57 |
NDAs: | 135 |
Drug Master File Entries: | 26 |
Finished Product Suppliers / Packagers: | 65 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Clinical Trials: | 248 |
Patent Applications: | 7,039 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for triamcinolone acetonide |
Drug Sales Revenues: | Drug sales revenues for triamcinolone acetonide |
What excipients (inactive ingredients) are in triamcinolone acetonide? | triamcinolone acetonide excipients list |
DailyMed Link: | triamcinolone acetonide at DailyMed |
Recent Clinical Trials for triamcinolone acetonide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kartal City Hospital | N/A |
University of Southern California | Early Phase 1 |
Oxular Limited | Phase 2 |
Pharmacology for triamcinolone acetonide
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide
US Patents and Regulatory Information for triamcinolone acetonide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro Pharm Inds Ltd | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 040037-001 | Sep 30, 1994 | AT | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Sun Pharm Inds Inc | KENALOG | triamcinolone acetonide | SPRAY;TOPICAL | 012104-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Astellas | ARISTOCORT | triamcinolone acetonide | OINTMENT;TOPICAL | 080750-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Teva | TRIACET | triamcinolone acetonide | CREAM;TOPICAL | 084908-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for triamcinolone acetonide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | See Plans and Pricing | See Plans and Pricing |
Abbvie | AZMACORT | triamcinolone acetonide | AEROSOL, METERED;INHALATION | 018117-001 | Apr 23, 1982 | See Plans and Pricing | See Plans and Pricing |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | See Plans and Pricing | See Plans and Pricing |
Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for triamcinolone acetonide
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 20160005735 | 안구용 주사를 위한 장치 및 방법 (APPARATUS AND METHODS FOR OCULAR INJECTION) | See Plans and Pricing |
Chile | 2013000347 | Poblacion de microparticulas que comprenden un corticoesteroide clase b incorporado en una matriz formada por un copolimero de acido lactico y acido glicolico, donde dicho corticoesteroide comprende entre 22% a 28% de las microparticulas; preparacion de liberacion controlada; formulacion; y metodo de fabricacion. | See Plans and Pricing |
Japan | 5581227 | See Plans and Pricing | |
Israel | 222638 | התקנים למתן תרופה לרקמה עינית על ידי מיקורמחט ותכשירים עבורם (Devices for drug delivery to ocular tissue comprising a microneedle and compositions for use therein) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.